Clinical efficacy of mTOR inhibitors in solid tumors: a systematic review.
about
Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate VaccinationImmune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesChemopreventive effects of a low-side-effect antibiotic drug, erythromycin, on mouse intestinal tumorsPro-survival responses to the dual inhibition of anti-apoptotic Bcl-2 family proteins and mTOR-mediated signaling in hypoxic colorectal carcinoma cellsCurrent Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists.Therapeutic potential of mTOR inhibitors for targeting cancer stem cells.Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.Traditional Chinese medicine Danggui Buxue Tang inhibits colorectal cancer growth through induction of autophagic cell death.mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells.Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma.Harnessing the mTOR Pathway for Tuberculosis Treatment.The prognostic value of p62 in solid tumor patients: a meta-analysis.On the pathogenesis of mTOR inhibitor-associated stomatitis (mIAS)-studies using an organotypic model of the oral mucosa.Effects of NVP-BEZ235, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on HTLV-1-infected T-cell lines.The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis.
P2860
Q28074536-B1B812B1-BA0C-44DA-83EF-1AC4B321DBD4Q28081001-DCED9593-6D1C-43E4-9238-5AEEA38B8848Q33751119-EF71F77E-CB5C-41DD-8BDB-8BCBF93DCEA8Q36086722-D7F8A1D2-8413-4349-8565-B5DBB71D0EC4Q37589535-CC028246-3573-4534-BB8E-84931924B812Q38648562-D74B842B-B5D4-40DE-8502-14F03B71BFD0Q38758962-7928198F-8CB9-4743-9662-7DE7B85E3CA4Q39134670-9120D2EE-1FEE-4DA3-8ADC-4B14CA0A0274Q47098816-6B46DD03-4E74-4AC7-8B2E-553904055A90Q47110074-11D44909-958B-45F7-ACA6-82212103D5BBQ47116845-968B31C9-3135-4E50-88FF-8A6EC070F439Q47412586-498C68CF-A473-4B3A-A300-E2A0F8830A05Q48012424-90F43D44-25FC-4F20-80C1-5FD486B1BD8AQ49417693-02315999-CE0D-44EF-94BC-8631D07FB81BQ49436326-EF47DDF6-B84F-44DF-96A3-27959E7E3D5CQ51038341-3587EA02-D8DF-4305-AD33-7BEFD9F40D65Q52649710-F9BB1631-7903-4FDF-BA6A-0D64B4F326D5Q52727884-D5D073AD-3ABE-49DE-AEA8-071D852E2BCC
P2860
Clinical efficacy of mTOR inhibitors in solid tumors: a systematic review.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical efficacy of mTOR inhibitors in solid tumors: a systematic review.
@en
type
label
Clinical efficacy of mTOR inhibitors in solid tumors: a systematic review.
@en
prefLabel
Clinical efficacy of mTOR inhibitors in solid tumors: a systematic review.
@en
P2093
P2860
P356
P1433
P1476
Clinical efficacy of mTOR inhibitors in solid tumors: a systematic review.
@en
P2093
Jiaqi Qian
Yongqian Shu
Zebo Huang
P2860
P304
P356
10.2217/FON.15.70
P407
P577
2015-01-01T00:00:00Z